Comparison

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

 

Click on the organs and learn more about cancer types

´

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

2719 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Nerelimomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5708-1mg

IchorBio
1 mg Login
Compare
Nerelimomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5708-25mg

IchorBio
25 mg Login
Compare
Nerelimomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5708-50mg

IchorBio
50 mg Login
Compare
Nerelimomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5708-5mg

IchorBio
5 mg Login
Compare
Nezutatug Biosimilar -­ Research Grade Hu FA CHO cells ICH5710-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Nezutatug Biosimilar -­ Research Grade Hu FA CHO cells ICH5710-1mg

IchorBio
1 mg Login
Compare
Nezutatug Biosimilar -­ Research Grade Hu FA CHO cells ICH5710-25mg

IchorBio
25 mg Login
Compare
Nezutatug Biosimilar -­ Research Grade Hu FA CHO cells ICH5710-50mg

IchorBio
50 mg Login
Compare
Nezutatug Biosimilar -­ Research Grade Hu FA CHO cells ICH5710-5mg

IchorBio
5 mg Login
Compare
Nisevokitug Biosimilar -­ Research Grade Hu FA CHO cells ICH5713-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Nisevokitug Biosimilar -­ Research Grade Hu FA CHO cells ICH5713-1mg

IchorBio
1 mg Login
Compare
Nisevokitug Biosimilar -­ Research Grade Hu FA CHO cells ICH5713-25mg

IchorBio
25 mg Login
Compare
Nisevokitug Biosimilar -­ Research Grade Hu FA CHO cells ICH5713-50mg

IchorBio
50 mg Login
Compare
Nisevokitug Biosimilar -­ Research Grade Hu FA CHO cells ICH5713-5mg

IchorBio
5 mg Login
Compare
Oberotatug Biosimilar -­ Research Grade Hu FA CHO cells ICH5718-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Oberotatug Biosimilar -­ Research Grade Hu FA CHO cells ICH5718-1mg

IchorBio
1 mg Login
Compare
Oberotatug Biosimilar -­ Research Grade Hu FA CHO cells ICH5718-25mg

IchorBio
25 mg Login
Compare
Oberotatug Biosimilar -­ Research Grade Hu FA CHO cells ICH5718-50mg

IchorBio
50 mg Login
Compare
Oberotatug Biosimilar -­ Research Grade Hu FA CHO cells ICH5718-5mg

IchorBio
5 mg Login
Compare
Obexelimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5719-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Obexelimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5719-1mg

IchorBio
1 mg Login
Compare
Obexelimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5719-25mg

IchorBio
25 mg Login
Compare
Obexelimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5719-50mg

IchorBio
50 mg Login
Compare
Obexelimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5719-5mg

IchorBio
5 mg Login
Compare
Ocaratuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5721-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Name Price
Nerelimomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Nerelimomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Nerelimomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Nerelimomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Nezutatug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Nezutatug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Nezutatug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Nezutatug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Nezutatug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Nisevokitug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Nisevokitug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Nisevokitug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Nisevokitug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Nisevokitug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Oberotatug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Oberotatug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Oberotatug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Oberotatug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Oberotatug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Obexelimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Obexelimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Obexelimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Obexelimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Obexelimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Ocaratuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available

2719 Item(s)

per page